Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

Chardan assumes Rocket Pharmaceuticals stock coverage with buy rating - investing.com

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

MIRA Pharmaceuticals reports toxicology data for pain drug candidate - investing.com

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

MIRA Pharmaceuticals posts positive 7-day tox results for MIRA-55, targets Q1 2027 IND - TradingView

news.google.com · 01 Sep 2026

Google News – Biopharma External News

Cipla licenses cancer bispecific from China’s Sino Biopharma - pharma.economictimes.indiatimes.com

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Canaccord reiterates Jazz Pharmaceuticals stock rating on trial data - investing.com

news.google.com · 01 Sep 2026

Google News – Biopharma External News

RedHill Biopharma (RDHL) Secures Exclusive Commercialization Rig - GuruFocus

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Redefining the standard for recessed lighting in the pharmaceutical industry - European Pharmaceutical Review

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Collaborations Pharmaceuticals and RTI International awarded an SBIR for long-acting treatment for HIV - EIN News

news.google.com · 01 Sep 2026

Google News – Biopharma External News

RedHill Biopharma (RDHL) Acquires Commercial Rights for Rebyota and Clenpiq, Faces Valuation Challenges - GuruFocus

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Is Amylyx Pharmaceuticals (AMLX) Expensive As Phase 3 Avexitide Data Clears The Way? - simplywall.st

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - PR Newswire

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - prnewswire.com

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Novartis pauses trials of experimental cell therapy after three deaths - PharmaLive

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals - The National Law Review

news.google.com · 01 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Chardan assumes Rocket Pharmaceuticals stock coverage with buy rating - investing.com

MIRA Pharmaceuticals reports toxicology data for pain drug candidate - investing.com

MIRA Pharmaceuticals posts positive 7-day tox results for MIRA-55, targets Q1 2027 IND - TradingView

Cipla licenses cancer bispecific from China’s Sino Biopharma - pharma.economictimes.indiatimes.com

Canaccord reiterates Jazz Pharmaceuticals stock rating on trial data - investing.com

RedHill Biopharma (RDHL) Secures Exclusive Commercialization Rig - GuruFocus

Redefining the standard for recessed lighting in the pharmaceutical industry - European Pharmaceutical Review

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

Collaborations Pharmaceuticals and RTI International awarded an SBIR for long-acting treatment for HIV - EIN News

RedHill Biopharma (RDHL) Acquires Commercial Rights for Rebyota and Clenpiq, Faces Valuation Challenges - GuruFocus

Is Amylyx Pharmaceuticals (AMLX) Expensive As Phase 3 Avexitide Data Clears The Way? - simplywall.st

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - PR Newswire

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - prnewswire.com

Novartis pauses trials of experimental cell therapy after three deaths - PharmaLive

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals - The National Law Review